GAD1 and schizophrenia: We further report that the behavioral abnormalities induced by ketamine exposure are associated with long-lasting abnormalities within the prefrontal GABAergic system, including decreased number of PV+ cells and reduced expression of GAD67 in the PFC, two molecular markers of the schizophrenia brain.